CPHI India launches India Pharma Week in celebration of its 10th anniversary
10 events to drive India’s rapid pharma growth predicted to reach $55bn by 2020.
CPHI India, organised by UBM EMEA, celebrates its 10th anniversary in 2016, and 9 years of collaboration with P-MEC India, with the first ever CPHI India Pharma Week (17-23 November 2016) – bringing 10 events in one week to the heart of Indian Pharma, in Mumbai. CPHI and P-MEC India is South Asia’s number one event for pharmaceutical sourcing and remains the key hub for the industry’s leading decision makers, executives and suppliers to gather, network and grow business opportunities.
India’s largest city is once again set to welcome more than 40,000 attendees across the seven-day event. This year, such is the size of CPHI & P-MEC India, that the show will take place in two venues simultaneously – the Bombay Exhibition Centre and at the MMRDA Grounds (BKC) and together they will host over 1,200 exhibitors from 100+ countries.
The Indian pharma market is growing at CAGR of 16% and is expected to be worth USD 55 billion in 2020. The country remains the leading global exporter of APIs and a prime pharma hub, producing a third of the world’s medicines, including an emerging cradle of new drugs. Unsurprisingly, it therefore boasts over 300 large companies and a further 10,000 SMEs – with less than one-fourth of these producing APIs vs. 77% making formulations. Within formulations, the biosimilar sector is also evolving rapidly as India’s surging segment expected to touch $1.4 billion in 2016, growing at a rate of 30% per year.
CPHI India has been integral to the growth and development in the India pharma economy and to celebrate this rapid advancement, this year a week long programme will feature all aspects of this diverse region. The first CPHI India Pharma Week will bring together the best that the Indian pharma industry has to offer, with an agenda that encompasses the themes of business, knowledge, leadership, innovation, recognition and networking.
Returning in 2016 as part of the India Pharma Week is the second Pre-Connect Congress, providing a knowledge-sharing platform featuring in-depth discussions, industry analysis and interactive thought-leading sessions. Adding to the content focus of the event, CPHI and P-MEC India will launch its CPHI Pharma Insights Report: India, discussing the current market and future prospects for the pharma economy in the next 3-5 years.
Pharma Week will also host the CPHI Women in Pharma Power Breakfast, which gathers female pharma executives from different parts of the world to share their expertise and commend the contribution of women within the Indian Pharma Industry.
Pharma leaders and key stakeholders will attend the CEO roundtable to discuss key challenges around policymaking, industry growth and sustainability. Additionally, UBM India offers local and international attendees the opportunity to attend plant visits, and see first-hand some of the advanced facilities in the country.
Finally, the UBM India Pharma Awards, return once again to recognise the excellence and innovations emerging from the pharma industry.
Additional features in 2016 include· The CPHI Exhibitor Showcase, which allows exhibiting companies to present their products, services and new launches in 45-minute slots
· The CPHI Innovation Gallery provides the opportunity for companies to showcase their innovations on an international platform in the Pharma Forum
· The Mobile App is available for all mobile devices and helps users access the complete exhibitor list, navigate floor plans, and connect with social media updates
· CPHI TV will bring live interviews from the top companies on the show floor, broadcasting on screens during the event and online on the website
Rutger Oudejans, Brand Director Pharma at UBM EMEA, said: “This year we are celebrating not only 10 years of CPHI India, but also the development of the Indian pharma industry. Seeing this pharma economy transform in the last decade, it has rapidly moved up the value chain from ingredients to finished formulations and now supplies 40% of generic medicines sold in the US. The increasing demand for generics and Indian produced ingredients along with international partnerships are ensuring double-digit growth across this huge pharma industry. Mirroring the development and changes in the market, and in recognition of Indian pharma, this year we have grown from a three-day exhibition to an event spanning the whole week and every aspect of its diverse supply chain.”
Related News
-
News A Day in the Life of a Pharma Event Director
The Day in the Life of series has covered most of the pharmaceutical supply chain looking through the eyes of the people working in the different fields, from R&D to manufacturing. What we haven't seen yet, is the role that non-pharma companies can... -
News On Track at CPHI Milan: The RTU Alliance on the importance of packaging innovation
As CPHI Milan gets ever closer, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma, and the innovations that are set to shake up the industry. -
News CPHI Milan Speaker Spotlight: The microbiome and investing in future therapies
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conference. -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News Latest updates for semaglutide: reduction of renal failure risk
Recent data presented at the 2024 European Society for Cardiology (ESC) conference analysed Novo Nordisk’s Ozempic (semaglutide) and its effectiveness in the management of chronic kidney disease (CKD). This follows previous analysis on semaglutid... -
News CPHI Milan Speaker Spotlight: CDMO relations with Pharma and Start-Ups
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News What can you expect from CPHI Milan 2024?
CPHI Milan 2024 marks the 35th anniversary of CPHI. The 35th Edition of the show, taking place 8–10 October, promises to be a celebration of everything pharma, covering every sector, and featuring thought leaders and trailblazers shaking up the i...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance